AMERICAN CANNABIS CO (AMMJ) Financials

AMMJ

FY2023 annual

Revenue $2.5M -86.8% YoY

Net Income -$3.7M -478.1% YoY

Free Cash Flow -$82K +72.9% YoY

Operating Cash Flow -$43K +78.4% YoY

Market Cap $74K as of Sep 15, 2026

Price / Sales 0.0x on $1.6M revenue, trailing 12 months to June 30, 2024

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2024

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2024

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2024, ended Jun 30, 2024 Reported Feb 11, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2024, filed Feb 11, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMMJ SEC filings page.

AMERICAN CANNABIS CO (AMMJ) reported $2.5M in revenue for fiscal year 2023, down 86.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMMJ FY2023 2026-08-30

American Cannabis’s dominant mechanic is volatile revenue paired with gross-margin recovery that still fails to absorb operating costs.

Revenue contraction brought FY2023 revenue down to $2.5M, while gross margin recovered from 13.5% in FY2022. Yet operating margin deteriorated to -155.5%, showing that the improved product-level margin was overwhelmed by costs below gross profit rather than converted into operating earnings.

Balance-sheet compression left FY2023 liabilities of $2.8M virtually equal to assets of $2.8M. A current ratio of 0.4x indicates short-term obligations exceeded current assets, a much tighter structure than FY2020’s 7.1x.

Earnings quality diverged sharply: FY2023 net loss was $3.7M, versus operating cash flow of -$43K. Free cash flow of -$82K likewise points to modest investment spending, so the reported loss was driven largely by items that did not require equivalent cash outflow.

Financial Health Signals

Financial health score not available

AMERICAN CANNABIS CO does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-10.94

AMERICAN CANNABIS CO scores -10.94, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($74K) relative to total liabilities ($2.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

AMERICAN CANNABIS CO passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

AMERICAN CANNABIS CO reported a net loss of $3.7M while operations used $43K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

AMERICAN CANNABIS CO reported an operating loss of $3.9M against $114K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$432K

YoY-49.4%

QoQ+68.9%

5Y CAGR-10.0%

AMERICAN CANNABIS CO generated $432K in revenue in Q2 2024. This represents a decrease of 49.4% from the same quarter a year earlier. Against the prior quarter it is up 68.9%.

EBITDA

-$497K

YoY-588.2%

QoQ-767.7%

AMERICAN CANNABIS CO's EBITDA was -$497K in Q2 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 588.2% from the same quarter a year earlier. Against the prior quarter it is down 767.7%.

Net Income

-$636K

YoY-5471.3%

QoQ-379.9%

AMERICAN CANNABIS CO reported -$636K in net income in Q2 2024. This represents a decrease of 5471.3% from the same quarter a year earlier. Against the prior quarter it is down 379.9%.

EPS (Diluted)

$0.00

AMERICAN CANNABIS CO earned $0.00 per diluted share (EPS) in Q2 2024.

Cash & Balance Sheet

Cash & Debt

$3K

YoY-97.0%

QoQ-72.7%

5Y CAGR-68.7%

10Y CAGR-37.5%

AMERICAN CANNABIS CO held $3K in cash as of Q2 2024; long-term debt is not reported for that period.

Shares Outstanding

186M

QoQ0.0%

5Y CAGR+28.6%

AMERICAN CANNABIS CO had 186M shares outstanding in Q2 2024. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2024.

Dividends Per Share

Not reported for Q2 2024.

Margins & Returns

Gross Margin

-70.2%

YoY-113.1pp

QoQ-111.5pp

5Y change-138.7pp

AMERICAN CANNABIS CO's gross margin was -70.2% in Q2 2024, indicating the percentage of revenue retained after direct costs. This is down 113.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 111.5 percentage points.

Operating Margin

Not shown for Q2 2024: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2024: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q2 2024.

Capital Allocation

None of these metrics is reported for Q2 2024.

AMMJ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMMJ quarterly income statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Revenue	$1.6M	$2.5M-86.8%	$18.8M+675.5%	$2.4M+54.5%	$1.6M-26.3%	$2.1M+116.9%	$982K-59.8%	$2.4M+56.5%	$1.6M-44.3%	$2.8M+122.4%	$1.3M	N/A	$3.9M+94.0%	$2.0M	N/A	N/A
Cost of Revenue	N/A	$1.4M-91.2%	$16.3M+1088.5%	$1.4M+61.2%	$849K+7.2%	$792K+51.1%	$524K-35.0%	$806K+16.5%	$692K-65.4%	$2.0M+159.3%	$771K	N/A	$2.5M	N/A	N/A	N/A
Gross Profit	$202K	$1.0M-58.9%	$2.5M+140.2%	$1.1M+46.5%	$721K-46.2%	$1.3M+192.0%	$459K-72.0%	$1.6M+88.3%	$869K+8.7%	$800K+64.0%	$488K	N/A	$1.4M+70.4%	$840K	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	$347-41.2%	$590-75.4%	$2K-5.9%	$3K-95.0%	$51K+297.4%	$13K	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.0M	$1.7M-41.7%	$2.8M+38.2%	$2.1M+102.8%	$1.0M-3.7%	$1.0M+20.9%	$868K-16.7%	$1.0M-5.2%	$1.1M+60.1%	$687K-81.2%	$3.7M	N/A	-$2.5M-110.7%	-$1.2M	N/A	N/A
Operating Income	-$4.0M	-$3.9M-535.9%	-$606K+63.1%	-$1.6M-162.9%	-$624K-86.9%	-$334K+66.8%	-$1.0M	N/A	N/A	N/A	N/A	N/A	$413K+360.7%	$90K	N/A	N/A
EBITDA	N/A	-$3.8M-574.0%	-$563K+63.6%	-$1.5M-153.3%	-$610K-86.4%	-$327K+67.3%	-$1.0M	N/A	N/A	N/A	N/A	N/A	$413K+360.7%	$90K	N/A	N/A
Interest Expense	$139K	$114K+45.5%	$78K+3.6%	$75K+4120.3%	$2K	N/A	$52-98.9%	$5K0.0%	$5K0.0%	$5K+101.8%	-$263K-165.1%	-$99K-102.7%	-$49K-244.9%	-$14K	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$31K-89.6%	$304K+1445.8%	$20K	N/A	N/A
Net Income	-$3.9M	-$3.7M-478.1%	-$633K+56.0%	-$1.4M-170.3%	-$532K-76.4%	-$302K+68.3%	-$951K+36.1%	-$1.5M-146.6%	-$604K-17.1%	-$516K+85.8%	-$3.6M	N/A	-$329K-689.2%	$56K-45.6%	$103K+119.5%	-$526K
EPS (Basic)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.11-1000.0%	-$0.01	N/A	$0.00	$0.00	N/A	N/A
EPS (Diluted)	—	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$0.11	-$0.01	N/A	$0.00	$0.00	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	45M	33M	N/A	2.45B0.0%	2.45B	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Revenue	$432K-49.4%	$256K-64.1%	$311K-97.3%	$600K-71.8%	$853K-82.0%	$712K+14.9%	$11.3M+1458.7%	$2.1M+182.0%
Cost of Revenue	$735K+51.1%	$150K-65.6%	N/A	N/A	$486K-88.1%	$436K-3.6%	$9.9M+2129.8%	$1.9M+339.5%
Gross Profit	-$303K-182.7%	$106K-61.8%	$150K-89.8%	$249K-4.0%	$366K-42.8%	$277K+65.0%	$1.5M+416.6%	$259K-21.2%
SG&A Expenses	$249K-43.1%	$232K-64.4%	$233K-73.5%	$326K-47.1%	$438K-40.9%	$653K+10.2%	$882K+40.3%	$617K+14.4%
Operating Income	-$557K-320.5%	-$129K+70.8%	-$3.1M-657.3%	-$129K+73.0%	-$132K+27.8%	-$441K+13.4%	$565K+171.0%	-$478K-83.0%
EBITDA	-$497K-588.2%	-$57K+84.9%	-$3.3M-762.4%	-$69K+84.2%	-$72K+51.4%	-$379K+19.5%	$494K+163.6%	-$437K-127.2%
Interest Expense	$83K+152.1%	$7K-76.4%	$78K+274.5%	-$29K-137.1%	$33K+79.5%	$32K+16.6%	-$45K-256.5%	$77K+176.1%
Net Income	-$636K-5471.3%	-$133K+74.6%	-$3.0M-754.3%	-$157K+60.5%	$12K+106.9%	-$522K0.0%	$457K+157.9%	-$398K-151.2%
EPS (Basic)	$0.00	$0.00+100.0%	N/A	$0.00	$0.00	-$0.010.0%	N/A	$0.00
EPS (Diluted)	$0.00	N/A	N/A	N/A	$0.00	N/A	N/A	N/A
Diluted Shares (Avg)	186M	86M	N/A	N/A	86M	86M	N/A	N/A

Not reported in any period shown, so not listed: R&D Expenses, Income Tax.

AMMJ Balance Sheet

AMMJ quarterly balance sheet

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Total Assets	$2.8M-38.7%	$4.6M+9.3%	$4.2M+123.6%	$1.9M+56.8%	$1.2M-5.6%	$1.3M-31.4%	$1.9M+88.9%	$984K+34.6%	$731K+55.5%	$470K+1781.9%	$25K-97.8%	$1.1M+122.2%	$517K	N/A	N/A
Current Assets	$900K-12.0%	$1.0M+0.8%	$1.0M-45.6%	$1.9M+60.1%	$1.2M-8.2%	$1.3M-31.4%	$1.8M+90.8%	$968K+35.7%	$713K+54.4%	$462K+1888.9%	$23K-96.7%	$700K+35.6%	$517K	N/A	N/A
Cash & Equivalents	$21K-82.1%	$118K-82.5%	$670K-61.1%	$1.7M+82.3%	$945K-13.0%	$1.1M-34.1%	$1.6M+119.4%	$751K+35.1%	$556K+236.4%	$165K+838.9%	$18K-88.0%	$146K-24.3%	$193K	$0	N/A
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Inventory	$586K+66.1%	$353K+26.7%	$279K+346.5%	$62K+17.1%	$53K-12.6%	$61K+70.6%	$36K-15.9%	$43K-37.0%	$67K+51.2%	$45K	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$234K-50.0%	$469K+4045.6%	$11K-54.7%	$25K-73.9%	$96K+62.4%	$59K-59.9%	$147K-10.7%	$164K+240.6%	$48K-16.2%	$58K	N/A	$485K+201.2%	$161K	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A
Goodwill	N/A	$1.3M-32.9%	$2.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.8M+4.3%	$2.7M+28.9%	$2.1M+705.7%	$261K-19.5%	$324K+20.1%	$270K-68.3%	$853K+159.2%	$329K-44.5%	$593K+53.7%	$386K+2223.6%	$17K-98.6%	$1.2M+161.0%	$466K	N/A	N/A
Current Liabilities	$2.2M+3.3%	$2.1M+8.8%	$1.9M+638.7%	$261K-19.5%	$324K+20.1%	$270K	N/A	$329K-44.5%	$593K+53.7%	$386K+2223.6%	$17K-97.9%	$779K+67.3%	$466K	N/A	N/A
Non-Current Liabilities	$660K+7.7%	$613K+250.3%	$175K	$0	$0	$0+100.0%	-$224K	$0	$0	$0	N/A	$436K	$0	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A
Total Equity	$2K-99.9%	$1.9M-11.8%	$2.1M+30.2%	$1.6M+85.0%	$880K-12.5%	$1.0M0.0%	$1.0M+53.5%	$655K+375.0%	$138K+63.5%	$84K+906.8%	$8K+112.4%	-$68K-232.6%	$51K+101.8%	-$2.8M+3.5%	-$2.9M
Retained Earnings	-$13.7M-36.3%	-$10.1M-6.7%	-$9.4M-18.0%	-$8.0M-7.1%	-$7.5M-4.2%	-$7.2M-15.3%	-$6.2M-31.4%	-$4.7M-14.6%	-$4.1M-14.3%	-$3.6M-47805.7%	$8K+102.8%	-$273K-589.2%	$56K	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Total Assets	$2.1M-52.3%	$2.6M-40.4%	$2.8M-38.7%	$4.2M-2.5%	$4.5M-7.4%	$4.4M-53.4%	$4.6M+9.3%	$4.3M-3.5%
Current Assets	$419K-57.3%	$818K-5.0%	$900K-12.0%	$803K-14.8%	$982K-33.1%	$861K-86.4%	$1.0M+0.8%	$943K-25.3%
Cash & Equivalents	$3K-97.0%	$10K-82.2%	$21K-82.1%	$9K-95.4%	$93K-89.4%	$56K-98.7%	$118K-82.5%	$192K-78.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$266K-47.7%	$670K+79.3%	$586K+66.1%	$518K+47.0%	$508K+81.4%	$374K+17.8%	$353K+26.7%	$352K+27.1%
Accounts Receivable	$137K-53.4%	$121K-66.0%	$234K-50.0%	$202K-22.1%	$293K+42.8%	$355K+33.9%	$469K+4045.6%	$260K+475.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	$1.3M-32.9%	$1.3M-32.9%	$1.3M-32.9%	$1.3M-32.9%	$2.0M+29.7%
Total Liabilities	$2.8M-6.8%	$2.8M-5.7%	$2.8M+4.3%	$2.8M-7.1%	$3.0M-6.2%	$2.9M-62.2%	$2.7M+28.9%	$3.0M+82.5%
Current Liabilities	$2.2M+1.3%	$2.2M-1.4%	$2.2M+3.3%	$2.1M-29.4%	$2.2M-29.1%	$2.2M-69.1%	$2.1M+8.8%	$2.9M+77.7%
Non-Current Liabilities	$561K-29.0%	$605K-18.4%	$660K+7.7%	$738K+687.1%	$790K+742.9%	$742K+12.0%	$613K+250.3%	$94K+1033.8%
Total Equity	-$636K-142.6%	-$131K-108.8%	$2K-99.9%	$1.3M+5.3%	$1.5M-9.8%	$1.5M-14.7%	$1.9M-11.8%	$1.3M-54.8%
Retained Earnings	-$14.5M-37.8%	-$13.9M-31.6%	-$13.7M-36.3%	-$10.7M-1.1%	-$10.5M-3.9%	-$10.5M-5.8%	-$10.1M-6.7%	-$10.5M-21.7%

Not reported in any period shown, so not listed: Long-Term Debt.

AMMJ Cash Flow Statement

AMMJ quarterly cash flow statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Operating Cash Flow	$148K	-$43K+78.4%	-$199K+79.2%	-$958K-82.2%	-$526K-411.2%	-$103K+81.7%	-$562K-411.0%	$181K+123.0%	-$785K-626.0%	$149K+338.1%	$34K-38.3%	$55K+128.4%	-$194K-203.0%	$189K	N/A	N/A
Depreciation & Amortization	N/A	$56K+32.5%	$43K-55.4%	$96K+585.7%	$14K+113.3%	$7K+74.4%	$4K-16.5%	$4K-13.3%	$5K+44.7%	$4K+231.9%	$1K-98.7%	$86K	$0	$0	N/A	N/A
Stock-Based Compensation	N/A	$1.7M+551.8%	$266K+530.7%	$42K+40.8%	$30K-59.2%	$74K-0.3%	$74K-91.8%	$894K+5404.0%	$16K-86.9%	$124K-96.3%	$3.3M	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	$39K-62.3%	$104K-71.0%	$358K+15923.3%	$2K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	-$82K+72.9%	-$303K+77.0%	-$1.3M-149.2%	-$528K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	-$39K+62.3%	-$104K+92.9%	-$1.5M-549148.7%	$267+100.7%	-$39K	N/A	-$5K-37.8%	-$3K+61.2%	-$9K-110.5%	$83K+272.6%	-$48K-465.8%	-$8K	$0	N/A	N/A
Financing Cash Flow	-$209K	$15K+105.8%	-$250K-118.2%	$1.4M+5.2%	$1.3M	N/A	N/A	$721K-26.7%	$983K+293.4%	$250K+705.2%	$31K-16.0%	$37K-78.7%	$173K+635.7%	$24K	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$4K	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Operating Cash Flow	$31K-17.3%	-$11K+94.6%	$288K+207.4%	-$159K+72.5%	$37K+101.3%	-$209K-105.9%	-$268K+13.1%	-$578K-87.2%
Depreciation & Amortization	$60K-0.2%	$72K+16.8%	-$125K-76.9%	$60K+47.2%	$60K+71.9%	$61K+63.5%	-$71K-498.5%	$41K-40.7%
Stock-Based Compensation	N/A	$0-100.0%	N/A	N/A	$8K-76.8%	$9K-70.7%	N/A	$56K+575.3%
Investing Cash Flow	N/A	N/A	-$2-100.0%	$0+100.0%	-$9+99.7%	-$39K-374.1%	$12K+132.3%	-$104K-406.1%
Financing Cash Flow	-$38K-3907.5%	$249-99.9%	-$246K-235.3%	$75K	-$950+99.8%	$187K+101.8%	$182K+39.5%	$0-100.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AMMJ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMMJ quarterly financial ratios

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Gross Margin	42.1%+28.6pp	13.5%-30.1pp	43.5%-2.4pp	45.9%-16.9pp	62.8%+16.2pp	46.7%-20.4pp	67.0%+11.3pp	55.7%+27.1pp	28.6%-10.2pp	38.7%	N/A	36.2%-5.0pp	41.3%	N/A	N/A
Operating Margin	-155.5%	-3.2%+64.4pp	-67.7%-27.9pp	-39.8%-24.1pp	-15.7%	-102.4%	N/A	N/A	N/A	N/A	N/A	10.5%+6.1pp	4.4%	N/A	N/A
Net Margin	-147.8%	-3.4%+56.0pp	-59.4%-25.4pp	-33.9%-19.8pp	-14.2%+82.6pp	-96.8%-35.9pp	-60.9%-22.2pp	-38.7%-20.3pp	-18.4%	-287.5%	N/A	-8.3%-11.1pp	2.8%	N/A	N/A
Return on Equity	-236155.9%-236122.0pp	-33.9%+34.1pp	-67.9%-35.2pp	-32.7%+1.6pp	-34.3%+60.3pp	-94.6%+53.5pp	-148.1%-55.9pp	-92.2%+281.8pp	-374.0%+3916.3pp	-4290.2%	N/A	N/A	109.7%	N/A	N/A
Return on Assets	-129.4%-115.7pp	-13.7%+20.4pp	-34.1%-5.9pp	-28.2%-3.1pp	-25.1%+49.5pp	-74.5%+5.6pp	-80.1%-18.8pp	-61.4%+9.2pp	-70.5%+699.3pp	-769.9%	N/A	-28.7%-39.5pp	10.8%	N/A	N/A
Current Ratio	0.42-0.1x	0.490.0x	0.53-6.6x	7.14+3.5x	3.59-1.1x	4.69	N/A	2.94+1.7x	1.200.0x	1.20-0.2x	1.40+0.5x	0.90-0.2x	1.11	N/A	N/A
Debt-to-Equity	1824.21+1822.8x	1.45+0.5x	0.99+0.8x	0.16-0.2x	0.37+0.1x	0.27-0.6x	0.85+0.3x	0.50-3.8x	4.30-0.3x	4.57+2.6x	1.98	N/A	9.15	N/A	N/A
Asset Turnover	0.88-3.2x	4.07+3.5x	0.57-0.3x	0.83-0.9x	1.77+1.0x	0.77-0.5x	1.31-0.3x	1.59-2.2x	3.83+1.2x	2.68	N/A	3.44-0.5x	3.94	N/A	N/A
FCF Margin	-3.3%-1.7pp	-1.6%+52.6pp	-54.3%-20.6pp	-33.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Gross Margin	-70.2%-113.1pp	41.3%+2.5pp	48.3%+35.3pp	41.5%+29.3pp	43.0%+29.5pp	38.8%+11.8pp	13.0%-26.2pp	12.2%-31.5pp
Operating Margin	-128.9%	-50.4%+11.5pp	-1011.8%	-21.6%+1.0pp	-15.5%-11.7pp	-61.9%+20.2pp	5.0%	-22.5%+12.2pp
Net Margin	-147.3%	-51.8%+21.5pp	-961.8%	-26.2%-7.5pp	1.4%+5.0pp	-73.3%+10.9pp	4.0%	-18.7%+2.3pp
Return on Equity	N/A	N/A	-193092.1%-193116.5pp	-11.9%+19.8pp	0.8%+11.1pp	-35.3%-5.2pp	24.5%+61.8pp	-31.6%-25.9pp
Return on Assets	-30.0%-30.3pp	-5.0%+6.8pp	-105.8%-115.7pp	-3.8%+5.5pp	0.3%+3.8pp	-11.8%-6.3pp	9.9%+28.6pp	-9.3%-5.7pp
Current Ratio	0.19-0.3x	0.380.0x	0.42-0.1x	0.39+0.1x	0.450.0x	0.39-0.5x	0.490.0x	0.32-0.4x
Debt-to-Equity	N/A	N/A	1824.21+1822.8x	2.12-0.3x	1.98+0.1x	1.98-2.5x	1.45+0.5x	2.40+1.8x
Asset Turnover	0.200.0x	0.10-0.1x	0.11-2.3x	0.14-0.4x	0.19-0.8x	0.16+0.1x	2.45+2.3x	0.50+0.3x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: The current ratio is below 1.0 (0.42), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
AMERICAN CANNABIS CO AMMJ	FY2023	$2.5M	-$3.7M	N/A	$74K	—
1606 CORP CBDW	FY2025	$0	N/A	N/A	$134K	—
VPR BRANDS LP VPRB	FY2025	$3.6M	-$1.2M	-33.1%	$9.3M	—

Where AMERICAN CANNABIS CO Ranks

Frequently Asked Questions

What is AMERICAN CANNABIS CO's annual revenue?

AMERICAN CANNABIS CO (AMMJ) reported $2.5M in total revenue for fiscal year 2023. This represents a -86.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AMERICAN CANNABIS CO's revenue growing?

AMERICAN CANNABIS CO (AMMJ) revenue declined by 86.8% year-over-year, from $18.8M to $2.5M in fiscal year 2023.

Is AMERICAN CANNABIS CO profitable?

No, AMERICAN CANNABIS CO (AMMJ) reported a net income of -$3.7M in fiscal year 2023.

What is AMERICAN CANNABIS CO's EBITDA?

AMERICAN CANNABIS CO (AMMJ) had EBITDA of -$3.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is AMERICAN CANNABIS CO's gross margin?

AMERICAN CANNABIS CO (AMMJ) had a gross margin of 42.1% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is AMERICAN CANNABIS CO's return on equity (ROE)?

AMERICAN CANNABIS CO (AMMJ) has a return on equity of -236155.9% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

What is AMERICAN CANNABIS CO's free cash flow?

AMERICAN CANNABIS CO (AMMJ) recorded an outflow of $82K in free cash flow during fiscal year 2023. This represents a 72.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is AMERICAN CANNABIS CO's operating cash flow?

AMERICAN CANNABIS CO (AMMJ) recorded an outflow of $43K in operating cash flow during fiscal year 2023, representing cash used by core business activities.

What are AMERICAN CANNABIS CO's total assets?

AMERICAN CANNABIS CO (AMMJ) had $2.8M in total assets as of fiscal year 2023, including both current and long-term assets.

What are AMERICAN CANNABIS CO's capital expenditures?

AMERICAN CANNABIS CO (AMMJ) invested $39K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How many shares does AMERICAN CANNABIS CO have outstanding?

AMERICAN CANNABIS CO (AMMJ) had 171M shares outstanding as of fiscal year 2023.

What is AMERICAN CANNABIS CO's current ratio?

AMERICAN CANNABIS CO (AMMJ) had a current ratio of 0.42 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is AMERICAN CANNABIS CO's debt-to-equity ratio?

AMERICAN CANNABIS CO (AMMJ) had a debt-to-equity ratio of 1824.21 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is AMERICAN CANNABIS CO's return on assets (ROA)?

AMERICAN CANNABIS CO (AMMJ) had a return on assets of -129.4% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is AMERICAN CANNABIS CO's P/E ratio?

AMERICAN CANNABIS CO (AMMJ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2024). The market capitalization is $74K as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMERICAN CANNABIS CO's price-to-sales ratio?

AMERICAN CANNABIS CO (AMMJ) trades at 0.0x sales, its market capitalization divided by revenue of $1.6M revenue, trailing 12 months to June 30, 2024. The market capitalization is $74K as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does AMERICAN CANNABIS CO's liquidity compare with its operating cash outflow?

At the end of fiscal year 2023, AMERICAN CANNABIS CO (AMMJ) held $21K in cash, cash equivalents and investments, and reported an operating cash outflow of $43K over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is AMERICAN CANNABIS CO's Altman Z-Score?

AMERICAN CANNABIS CO (AMMJ) has an Altman Z-Score of -10.94, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is AMERICAN CANNABIS CO's Piotroski F-Score?

AMERICAN CANNABIS CO (AMMJ) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AMERICAN CANNABIS CO's earnings high quality?

AMERICAN CANNABIS CO (AMMJ) reported a net loss of $3.7M while operations used $43K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can AMERICAN CANNABIS CO cover its interest payments?

AMERICAN CANNABIS CO (AMMJ) reported an operating loss of $3.9M against $114K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.